Ballentine Partners, LLC Insulet Corp Transaction History
Ballentine Partners, LLC
- $6.57 Billion
- Q2 2025
A detailed history of Ballentine Partners, LLC transactions in Insulet Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 2,022 shares of PODD stock, worth $626,071. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,022
Previous 1,776
13.85%
Holding current value
$626,071
Previous $466,000
36.27%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding PODD
# of Institutions
856Shares Held
61.7MCall Options Held
428KPut Options Held
571K-
Vanguard Group Inc Valley Forge, PA8.71MShares$2.7 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY6.06MShares$1.88 Billion0.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.74MShares$1.47 Billion0.31% of portfolio
-
State Street Corp Boston, MA3.02MShares$936 Million0.03% of portfolio
-
Baillie Gifford & CO2.14MShares$661 Million0.53% of portfolio
About INSULET CORP
- Ticker PODD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 69,403,600
- Market Cap $21.5B
- Description
- Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...